Dallas Fort Worth Injury Lawyer Blog

August 21, 2009

Avandia Risk of Heart Failure and Lawsuits

If you believe you may have been harmed by the use of Avandia, it is important to note that your time to file a lawsuit against the maker of the drug could be running out. The statute of limitations in many states is coming up soon, and there still may be people who do not realize that the injury they have suffered could be related to their Avandia use.

New research shows that diabetics treated with the popular drug Avandia have higher risk of heart failure and death than those taking Actos, leading Canadian scientists to conclude that “continued use of [Avandia] may not be justified.”

The findings, published in today’s edition of the British Medical Journal, are the latest blow to the controversial blockbuster drug, manufactured by GlaxoSmithKline Inc.

Researchers stressed that the findings are relative and that Actos, a product of Takeda Pharmaceuticals North America Inc., also poses heart risks, albeit lesser ones.

August 21, 2009

Wastewater From MI Food Plants Getting Into Home Water Wells

by Dr. Shezad Malik

When Kari and Ron Craton moved a few years ago to a more rural area of southwestern Michigan, they were seeking a more rustic life. What they got was more rust.

Government officials say food-processing plants that turn raw crops into products have contaminated the water-supply wells of the Cratons and other property owners in agricultural areas of Michigan and could do the same in other states. Residents claim increased amounts of metals in water drawn from their wells have killed their pets, ruined their plumbing and made their houses impossible to sell or rent.

August 21, 2009

Gadolinium Nephrogenic Systemic Fibrosis (MRI Dye) and Lawsuits

by Dr. Shezad Malik

A dye used in MRI (magnetic resonance imaging) and MRA (magnetic resonance angiography) scans has been linked to a rare and potentially fatal skin disease in some users.

The problem stems from the metal gadolinium found in the dyes injected into some patients before MRI scans and all patients before MRA scans.

The disease is known as nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD), and appears to only occur in patients with kidney disease who undergo an MRI or MRA where a gadolinium-based dye is used.

August 21, 2009

Mercury Found in all Fish Caught in U.S.-Tested Streams

by Dr. Shezad Malik

A government test of fish pulled from nearly 300 streams in the USA found every one of them contaminated with some level of mercury.

The U.S. Geological Survey’s research marks its most comprehensive examination of mercury contamination in stream fish. The study found that 27% of the fish had mercury levels high enough to exceed what the Environmental Protection Agency considers safe for the average fish eater, those who eat fish twice a week.

But the findings in wild-caught fish underscore how widespread mercury contamination in the nation’s waterways has become. Previous research has found levels of concern in ocean and lake fish.

August 21, 2009

Yas/Yasmin JPML Hearing Set for September 24, 2009

by Dr. Shezad Malik

The Yasmin/Yaz lawyers at the Dr. Shezad Malik Law Firm are investigating potential Yasmin/Yaz lawsuits throughout the United States for claims on behalf of patients who took the drug and now suffer from deep vein thrombosis (blood clots in legs), pulmonary embolism, and/or strokes. Yasmin/Yaz have also been associated with heart attacks and death. These Yasmin/Yaz lawsuits allege product liability, negligence and failure to warn claims against Bayer Healthcare Pharmaceutical.

A MDL hearing has been set in the JPML Court in Richmond, Virginia on September 24, 2009.

August 21, 2009

Fleet Phospho Soda Side Effects and Lawsuits

by Dr. Shezad Malik

The Fleet Phospho-soda attorneys at Dr. Shezad Malik Law Firm are investigating potential lawsuits for individuals who have suffered severe kidney damage after a colonoscopy prep where Fleet Phospho-soda was used.

While most patients only became aware of the potential for Fleet Phospho-soda kidney problems when the product was recalled in December 2008, the manufacturer has been aware of the potential side effects for years.

August 21, 2009

Yasmin, YAZ, Ocella Birth Control Personal Injuries

by Dr. Shezad Malik

YAZ, also known as Yasmin or by its generic name Ocella is a birth control pill originally developed and manufactured by Berlex Laboratories, (a U.S affiliate of Schering AG).

YAZ, Yasmin, Ocella (drospirenone and ethinyl estradiol) is a combination birth control pill which contain two types of hormones: estrogen and a progestin. It is the only 24/4-day pill with the unique hormone, drospirenone (drsp) and its manufacturer claims that the product provides additional health benefits other then pregnancy prevention.

August 20, 2009

Fleet Phospho Soda and Kidney Damage

by Dr. Shezad Malik

Fleet Phospho Soda, a laxative product used for varying applications, was the subject of a December 2008 consumer alert from the FDA (the U.S. Food and Drug Administration). The alert warned that the use of phosphate-based laxatives such as Fleet Phospho Soda could result in kidney failure, even among individuals who do not have a medical condition that puts them at risk for kidney failure.

Fleet Phospho Soda is available without a prescription, it is a non-prescription laxative. It is widely used to clean the intestines before a colonoscopy and other medical procedures.

The Phospho Soda works by drawing fluid from the rest of the body into the colon; if an individual does not consume enough water or other fluids during Phospho Soda use, he or she may become dehydrated. The individual’s level of phosphate salts in the kidneys may also become too high — a development that can result in a type of kidney damage called acute phosphate nephropathy (APN).

August 20, 2009

Yaz and Yasmin Linked to Pulmonary Embolism, Heart Attacks and Strokes

by Dr. Shezad Malik

Yaz is a relatively new oral birth control medication. But an unfortunate number of patients have found, Yaz also causes serious, and life-threatening side effects including pulmonary embolism (blood clots to the lung), heart attack and stroke.

Bayer HealthCare Pharmaceuticals Inc. – the drug’s manufacturer – before being regulated by the U.S. Food and Drug Administration in a recent mandate, marketed Yaz which minimized these very serious side effects, and misleading millions of women about the safety of this medication.

If you’re taking the prescription medication Yaz or Yasmin, also manufactured by Bayer, and have had any of the side effects associated with these compounds, you may be entitled to compensation.

August 20, 2009

Court Overturns $53 M Awarded in Wrongful Death Nursing Home Case

by Dr. Shezad Malik

The state Court of Appeals has overturned a $53 million damage award to the family of an Albuquerque woman who died in a nursing home.

The court ordered a new trial. The daughter of 78-year Barbara Barber filed a lawsuit alleging her mother died in December 2004 of gastrointestinal bleeding that went untreated by the nursing home staff.

In tossing out the jury verdict, the appeals court said a district judge was wrong in a pretrial finding that ManorCare Inc., a Toledo, Ohio-based company, was the employer of the nursing home’s staff. The court said there was conflicting evidence on that issue. ManorCare contended that a subsidiary company owned and operated the Albuquerque nursing home, which was sold in 2005.